04 December 2020 : Database Analysis
Construction and Validation of a 7-Immune Gene Model for Prognostic Assessment of Esophageal Carcinoma
Haitao Chen1ABCEF, Jun Luo23BCD, Jianchun Guo23ADEF*DOI: 10.12659/MSM.927392
Med Sci Monit 2020; 26:e927392
Table 1 Clinical information of the 159 esophageal carcinoma patients in the entire cohort.
| Clinical traits | Variable | N (total=159) | Percentage (%) |
|---|---|---|---|
| Survival status | Alive | 95 | 59.7 |
| Dead | 64 | 40.3 | |
| Age (years) | ≤60 | 81 | 50.9 |
| >60 | 78 | 49.1 | |
| Gender | Female | 23 | 14.5 |
| Male | 136 | 85.5 | |
| Pathological stage | Stage I | 19 | 11.9 |
| Stage II | 74 | 46.5 | |
| Stage III | 55 | 34.6 | |
| Stage IV | 11 | 6.9 | |
| T | T0 | 2 | 1.3 |
| T1 | 28 | 17.6 | |
| T2 | 38 | 23.9 | |
| T3 | 87 | 54.7 | |
| T4 | 4 | 2.5 | |
| M | M0 | 130 | 81.8 |
| M1 | 11 | 6.9 | |
| MX | 18 | 11.3 | |
| N | N0 | 68 | 42.8 |
| N1 | 67 | 42.1 | |
| N2 | 16 | 10.1 | |
| N3 | 6 | 3.8 | |
| NX | 2 | 1.3 |